Therapeutically, TO901317 showed promise in HCC treatment by modulating LXRα and metabolic pathways, while studies highlighted the protective role of reduced glutathione against alcohol-induced liver injury. This evidence concerns the gene NR1H3 and hepatocellular carcinoma.